Send us a Message



Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   

GENE - CHEMICAL INTERACTIONS REPORT

RGD ID: 731072
Species: Homo sapiens
RGD Object: Gene
Symbol: VEGFA
Name: vascular endothelial growth factor A
Acc ID: CHEBI:27899
Term: cisplatin
Definition: A diamminedichloroplatinum compound in which the two ammine ligands and two chloro ligands are oriented in a cis planar configuration around the central platinum ion. An anticancer drug that interacts with, and forms cross-links between, DNA and proteins, it is used as a neoplasm inhibitor to treat solid tumours, primarily of the testis and ovary. Commonly but incorrectly described as an alkylating agent due to its mechanism of action (but it lacks alkyl groups).
Chemical ID: MESH:D002945
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction is comprised of a complex set of reactions and/or regulatory events, possibly involving additional chemicals and/or gene products.
Object SymbolQualifierEvidenceWithReferenceSourceNotesOriginal Reference(s)
VEGFAdecreases expressionEXP 6480464CTDCisplatin results in decreased expression of VEGFA mRNA; Cisplatin results in decreased expression of VEGFA proteinPMID:17498666
VEGFAincreases expressionEXP 6480464CTDCisplatin results in increased expression of VEGFA mRNAPMID:20935474 PMID:27594783 PMID:29690507
VEGFAmultiple interactionsEXP 6480464CTD[[Cisplatin co-treated with ciglitazone] results in decreased expression of VEGFA] which results in decreased abundance of Dinoprostone; [Cisplatin co-treated with ciglitazone] results in decreased expression of VEGFA; [Cisplatin co-treated with Methotrexate co-treated with Doxorubicin] results in increased expression of VEGFA protein; [Cisplatin co-treated with Paclitaxel] results in increased expression of VEGFA mRNA; [Cisplatin results in decreased susceptibility to Cisplatin] which results in increased expression of VEGFA mRNA; [Oxygen deficiency co-treated with eprenetapopt co-treated with Cisplatin] results in increased expression of VEGFA mRNA; Cisplatin promotes the reaction [HIF1A protein binds to VEGFA promoter]; eprenetapopt deficiency promotes the reaction [Cisplatin results in increased expression of VEGFA mRNA]; Topotecan inhibits the reaction [Cisplatin promotes the reaction [HIF1A protein binds to VEGFA promoter]]; Topotecan inhibits the reaction [Cisplatin results in increased expression of VEGFA mRNA]PMID:20158913 PMID:20705681 PMID:20935474 PMID:21681689 PMID:29690507 PMID:30871063
VEGFAmultiple interactionsISOVegfa (Mus musculus)6480464CTDCisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]; Cisplatin promotes the reaction [NPPC protein inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]]; NPPC protein promotes the reaction [Cisplatin inhibits the reaction [[9,10-Dimethyl-1,2-benzanthracene co-treated with Croton Oil] results in increased expression of VEGFA mRNA]]PMID:37352108
Go Back to source page   Continue to Ontology report